Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 20- Open
- $52.83
- 52-wk high
- $109.50
- High
- $52.99
- 52-wk low
- $42.20
- Low
- $51.70
- Prev close
- $51.69
Smart money
Earnings
Earnings came in 3.6% above what analysts expected.
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $5.07B | $5.29B | $5.20B | $5.44B |
| Cost of what it sold | $1.52B | $1.35B | $1.59B | $1.59B |
| Gross profit | $3.54B | $3.94B | $3.61B | $3.85B |
| What it spent | ||||
| Research and development | $514.0M | $569.0M | $516.0M | $554.0M |
| Sales and admin | $1.74B | $1.83B | $1.78B | $1.80B |
| Other operating costs | $237.0M | $328.0M | $244.0M | $313.0M |
| Total operating expenses | $2.49B | $2.73B | $2.54B | $2.67B |
| What was left | ||||
| Operating profit | $1.05B | $1.21B | $1.07B | $1.18B |
| Interest on debt | $87.0M | $90.0M | $90.0M | $96.0M |
| Profit before tax | $939.0M | $700.0M | $1.16B | $1.06B |
| Tax | $183.0M | $31.0M | -$176.0M | $155.0M |
| Net profit | $755.0M | $668.0M | $1.34B | $907.0M |
| EBITDA | $1.37B | $1.16B | $1.60B | $1.39B |
Technicals
Price structure
This stock is trending upward, and looks overbought after a fast run-up.
Trend
Constructive
60 / 100
RSI 14
20D volatility
52-week range
20D support
News
What the news says
Coverage is bullish
Tone of tracked coverage
Boston Scientific stock holds in the low $51 range as Q2 2026 margins and EPS beat guidance
BullishAug 18Mitsubishi UFJ Asset Management Co. Ltd. Buys New Holdings in Boston Scientific Corporation $BSX
BullishAug 18Conway Capital Management Inc. Takes $1.23 Million Position in Boston Scientific Corporation $BSX
Leans bullish